Swiss National Bank - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 239 filers reported holding ARRAY BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$18,815,000
+109.2%
406,100
+10.1%
0.02%
+100.0%
Q1 2019$8,994,000
+76.7%
368,900
+3.3%
0.01%
+42.9%
Q4 2018$5,089,000
-4.1%
357,100
+2.3%
0.01%
+16.7%
Q3 2018$5,305,000
-7.9%
349,000
+1.6%
0.01%
-14.3%
Q2 2018$5,762,000
+8.4%
343,400
+5.5%
0.01%
+16.7%
Q1 2018$5,314,000
+34.5%
325,600
+5.5%
0.01%
+50.0%
Q4 2017$3,951,000
+6.2%
308,700
+2.1%
0.00%0.0%
Q3 2017$3,720,000
+66.2%
302,400
+13.1%
0.00%
+33.3%
Q2 2017$2,238,000
+0.1%
267,400
+7.0%
0.00%0.0%
Q1 2017$2,235,000
+5.2%
250,000
+3.4%
0.00%0.0%
Q4 2016$2,125,000
+23.1%
241,800
-5.4%
0.00%0.0%
Q3 2016$1,726,000
+128.9%
255,700
+20.8%
0.00%
+200.0%
Q2 2016$754,000
+12.7%
211,700
-9.8%
0.00%0.0%
Q1 2016$669,000
-17.1%
234,800
+22.8%
0.00%
-50.0%
Q4 2015$807,000
-7.5%
191,2000.0%0.00%0.0%
Q3 2015$872,000
-27.3%
191,200
+15.0%
0.00%
-33.3%
Q2 2015$1,199,000
+13.0%
166,300
+15.5%
0.00%0.0%
Q1 2015$1,061,000
+55.8%
144,0000.0%0.00%0.0%
Q4 2014$681,000
+38.4%
144,000
+4.6%
0.00%
+50.0%
Q3 2014$492,000
-21.7%
137,7000.0%0.00%0.0%
Q2 2014$628,000
-2.9%
137,7000.0%0.00%
-33.3%
Q1 2014$647,000
+18.1%
137,700
+25.9%
0.00%
+50.0%
Q4 2013$548,000
-19.4%
109,4000.0%0.00%
-33.3%
Q3 2013$680,000
+31.5%
109,400
-3.9%
0.00%
+50.0%
Q2 2013$517,000113,8000.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q4 2018
NameSharesValueWeighting ↓
Redmile Group, LLC 15,978,580$268,121,0009.11%
BVF INC/IL 4,672,195$78,399,0007.65%
First Light Asset Management, LLC 2,391,575$40,131,0006.25%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 694,500$11,647,0004.47%
Copernicus Capital Management, LLC 286,797$4,812,0003.49%
PACIFIC VIEW ASSET MANAGEMENT, LLC 225,511$3,784,0003.00%
SECTORAL ASSET MANAGEMENT INC 1,566,477$26,285,0002.94%
X-Square Capital, LLC 173,802$2,917,0002.18%
DRIEHAUS CAPITAL MANAGEMENT LLC 2,618,654$43,941,0001.48%
Birchview Capital, LP 128,000$2,148,0001.46%
View complete list of ARRAY BIOPHARMA INC shareholders